Assessment of Safety and Pharmacokinetics of a Low Dose of Methotrexate in Healthy Adult Male Kenyan Volunteers
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Previous investigations indicate that methotrexate, an old anticancer drug, could be used at
low doses to treat malaria. This is a phase I evaluation to assess the safety and
pharmacokinetic profile of this drug in healthy adult male Kenyan volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
KEMRI-Wellcome Trust Collaborative Research Program